Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Terminated 2Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 174Leukemia, Myeloid, Acute 154Neoplasm Metastasis 147Breast Neoplasms 145Neoplasms 143Colorectal Neoplasms 134Recurrence 104Ovarian Neoplasms 100Multiple Myeloma 81Advanced Solid Tumor 81Pancreatic Neoplasms 80Lung Neoplasms 80Prostatic Neoplasms 76Advanced Solid Tumors 75Stomach Neoplasms 73Squamous Cell Carcinoma of Head and Neck 72Carcinoma, Hepatocellular 67Glioblastoma 66Melanoma 64Lymphoma, Non-Hodgkin 63Triple Negative Breast Neoplasms 57Myelodysplastic Syndromes 54Lymphoma, B-Cell 53Endometrial Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Glioma 51Lymphoma 49Brain Neoplasms 46Hematologic Neoplasms 44Carcinoma, Renal Cell 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Giant Cell Tumor of Tendon Sheath × Clear all
NCT04192344 2026-03-19

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

Abbisko Therapeutics Co, Ltd

Phase 1 Recruiting
276 enrolled

Giant Cell Tumor of Tendon Sheath, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡